Views & Analysis Ultra-rare disease drugs: has access in England just got har... Gaining access to ultra-orphan drugs could become much more difficult.
News Digital mental health platform Healios endorsed by NICE Healios endorsed for improving access to CBT for young people with anxiety.
Partner Content Partner Content Orphan medicines, advances, access and affordability LONDON, UNITED KINGDOM, April 19th 2017:
News NHS to axe 18-week ops waiting target Cancer care and mental health to take priority, says health chief.
News Charities unite to oppose NICE rare disease rules MPs to discuss controversial plan in special debate.
Views & Analysis Pharma could take NHS England to court over new delaying tac... New cost-capping and delaying measures will further restrict access to new medicines say pharma and patient groups.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
